Previous 10 | Next 10 |
2024-02-16 15:00:59 ET More on the markets SPY Pullback Triggers Sell Signal (Technical Analysis) SPY: Up 14 Weeks Out Of Last 15 - I'm Out SPY: Larger Treasury Issuances And Fewer Fed Cuts Are Not Priced In Investors retract capital from the fund market for ...
2024-02-16 10:29:22 ET More on Novartis Novartis And MorphoSys Are A Perfect Match Novartis AG (NVS) Q4 2023 Earnings Call Transcript Novartis AG 2023 Q4 - Results - Earnings Call Presentation MorphoSys ADRs gain after definitive merger agreement with Novarti...
2024-02-14 16:22:14 ET The company's revenue growth has been affected by increasing competition, including biosimilars and generics. They rely on discovering, developing, and commercializing innovative products, as well as acquiring or collaborating on therapies from other companies. Regulato...
2024-02-14 15:36:06 ET Amgen Inc. (AMGN) Oppenheimer 34th Annual Healthcare Life Sciences Conference February 14, 2024 12:00 PM ET Company Participants Justin Claeys - Vice President of Finance and Treasurer Murdo Gordon - Executive Vice President of Global Comme...
2024-02-14 02:59:00 ET Amgen (NASDAQ: AMGN) is well on its way to producing a medicine for obesity that could one day rival the blockbuster weight-loss drugs like Wegovy and Zepbound made by the segment's monarchs, Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) ....
2024-02-13 13:07:35 ET More on Eli Lilly Will Eli Lilly and Company Become A Trillion-Dollar Baby? Eli Lilly and Company: Even 'Miracle Drugs' Can't Keep Stock Rising (Downgrade) Eli Lilly and Co (LLY) Q4 2023 Earnings Conference Call Transcript Federal judge...
2024-02-13 00:50:00 ET Summary Let's take a look at the landscape for GLP-1 drug development (including the drugs that target associated hormones). Novo Nordisk has had a spectacular success with semaglutide (Ozempic/Wegovy), and its effects on weight loss have been established to...
2024-02-12 21:01:27 ET More on Bristol-Myers Squibb Company , Eli Lilly, etc. Pfizer Stock: It's Time To Buy The Dip Pfizer Is A Great Investment Over The Next Decade; Buy Will Eli Lilly and Company Become A Trillion-Dollar Baby? RayzeBio ticks higher af...
2024-02-12 13:03:02 ET Amgen ( NASDAQ: AMGN ) stock is trading in the green on Monday, on track to snap a six-day losing streak. Short interest on AMGN stands at 1.74% of total float.... Read the full article on Seeking Alpha For further details see: Amgen set to sna...
2024-02-11 12:00:03 ET More on Eli Lilly, Novo Nordisk, etc. Will Eli Lilly and Company Become A Trillion-Dollar Baby? Eli Lilly and Company: Even 'Miracle Drugs' Can't Keep Stock Rising (Downgrade) Eli Lilly and Co (LLY) Q4 2023 Earnings Conference Call Transcript ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-18 10:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-15 07:58:00 ET Can a biotechnology company pay a generous dividend in 2024? The answer is definitely yes, as Amgen (NASDAQ: AMGN) is evidently unafraid to reward its loyal shareholders with quarterly cash payments. Just as importantly, Amgen is a recent revenue growe...
2024-07-14 06:30:00 ET Income investors don't have to settle for dividends that tread water. There are plenty of stocks to buy that offer growing dividends and are poised to keep the momentum going along with attractive dividend yields . Three Motley Fool contributors think they've ...